Myeloperoxidase inhibition may protect against endothelial glycocalyx shedding induced by COVID-19 plasma
Description
CONCLUSIONS: Neutrophil MPO may increase EG shedding in COVID-19, and inhibiting MPO activity may protect against EG degradation. Further research is needed to evaluate the utility of MPO inhibitors as potential therapeutics against severe COVID-19.
